Streetbeat News

Analyst Ratings

ABOS

B of A Securities analyst Geoff Meacham has reinstated Acumen Pharmaceuticals (NASDAQ:ABOS) with a Buy rating and announced a $14 price target.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 10:52 am

FHN

RBC Capital analyst Jon Arfstrom has maintained a 'Sector Perform' rating on First Horizon (NYSE:FHN) and raised the price target from $13 to $14.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 10:51 am

EL

Barclays analyst Kannan Venkateshwar has downgraded Estee Lauder Cos (NYSE:EL) from Overweight to Equal-Weight.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 10:51 am

OC

Benchmark analyst Reuben Garner has downgraded Owens-Corning (NYSE:OC) from Buy to Hold.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 10:50 am

WAL

UBS analyst Brody Preston maintains a Buy rating on Western Alliance (NYSE:WAL) and raises the price target from $61 to $66.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 10:48 am

USB

Raymond James analyst David Long has upgraded U.S. Bancorp (NYSE:USB) from Underperform to Market Perform.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 10:46 am

NFLX

Pivotal Research analyst Jeffrey Wlodarczak has maintained a 'Buy' rating on Netflix (NASDAQ:NFLX) and raised the price target from $535 to $600.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 10:46 am

HST

Oppenheimer analyst Tyler Batory has upgraded Host Hotels & Resorts (NASDAQ:HST) from Perform to Outperform.

Portfolio Pulse from richadhand@benzinga.com

July 20, 2023 | 10:45 am

NOW

Oppenheimer analyst Brian Schwartz maintains an Outperform rating on ServiceNow (NYSE:NOW) and raises the price target from $500 to $640.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 10:43 am

TSLA

Barclays analyst Dan Levy has reiterated an Equal-Weight rating on Tesla (NASDAQ:TSLA) and maintained a price target of $260.

Portfolio Pulse from Benzinga Newsdesk

July 20, 2023 | 10:40 am